- About Us
- Research and Development
- AppTrim® Data Sheet
- AppTrim-D® Data Sheet
- GABAdone® Data Sheet
- Hypertensa® Data Sheet
- Lister V® Data Sheet
- Percura Prescribing Guide® Data Sheet
- Percura Sheet® Data Sheet
- Sentra AM® Data Sheet
- Sentra PM® Data Sheet
- Theramine® Data Sheet
- Trepadone® Data Sheet
- AppTrim® Package Insert
- AppTrim-D® Package Insert
- GABAdone® Package Insert
- Lister V® Package Insert
- Percura® Package Insert
- Product Portfolio® Package Insert
- Sentra AM® Package Insert
- Sentra PM® Package Insert
- Theramine® Package Insert
- Trepadone® Package Insert
- Quick Links
- Safety & Clinical Data
- Military Healthcare
- Military Healthcare Providers
- Gulf War Syndrome
- Sleep Disorders
- Autonomic Dysfunction
- Chronic Pain
- Heart Rate Variability
- Gulf War Syndrome and HRV
- Veteran and Military Healthcare Research and Events
- Federal Supply Schedule
- Recent Articles
- Quick Links
- Video: Reducing Side Effects of Medication
- Long Term Care
- Investor Relations
Los Angeles, September 27, 2012 — Physician Therapeutics, a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, will present data examining the effectiveness of its medical food Theramine® and low dose ibuprofen for the management of chronic back pain at several upcoming scientific conferences.
The scientific poster titled, “Theramine versus ibuprofen for the safe and effective management of chronic low back pain and inflammation,” was first presented on September 6 at PAINWeek 2012, held in Las Vegas, Nevada. The data is scheduled to be presented at scientific conferences and meetings in the next six months, including the 118th Annual Meeting of AMSUS in Phoenix, Arizona on November 13, 2012.
“Incorporating medical foods into pain management regimens is gaining wide attention and we are delighted to present these data to a national audience of physicians, pharmacists and psychologists, as well as a broad array of disciplines within the medical community,” said David S. Silver M.D., corresponding author of the abstract, and executive VP of medical and scientific affairs at Targeted Medical Pharma, Inc.
The randomized, double-blind placebo-controlled study of 130 patients sought to determine whether Theramine is an effective analgesic in the treatment of chronic back pain and if it could aid in reducing inflammatory markers. The full poster, including the study results, may be downloaded by visiting: (http://bit.ly/theraminevsibuprofen).
“Theramine versus Ibuprofen for the safe and effective management of chronic low back pain and inflammation.” William E. Shell M.D., David S. Silver M.D., Fred McCall-Perez Ph.D., Stephanie Pavlik C.R.A.
About Physician Therapeutics’ Medical Foods
Physician Therapeutics’ medical foods are amino acid based, FDA-regulated medications specially formulated to meet the body’s increased nutritional requirements of disease. They are a safe and effective option for treating pain syndromes, sleep and cognitive disorders, hypertension and obesity without harmful side effects. Physician Therapeutics’ medical foods are available by prescription only and must be administered under the ongoing supervision of a physician.
About Physician Therapeutics and Targeted Medical Pharma, Inc.
Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders, and hypertension. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are sold in the United States and Japan. The company manufactures nine proprietary medical foods, as well as 48 convenience pack kits, which pair a medical food and branded or generic pharmaceutical. These prescription medications and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.
- Targeted Medical Pharma to Present at Marcum Microcap Conference
- Targeted Medical Pharma Reports 2013 First Quarter Results
- Targeted Medical Pharma Pre-announces 2013 Unaudited Q1 Revenue
- Targeted Medical Pharma Announces Registration Statement
- Targeted Medical Pharma to Present at American Medical Society for Sports Medicine